levodopa has been researched along with 22q11 Deletion Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azulay, JP; Borg, M; Charles, P; Colin, O; Danaila, T; Drapier, S; Dufournet, B; Eusebio, A; Grabli, D; Jacquette, A; Mutez, E; Nguyen, K; Philip, N | 1 |
1 other study(ies) available for levodopa and 22q11 Deletion Syndrome
| Article | Year |
|---|---|
Parkinson's disease associated with 22q11.2 deletion: Clinical characteristics and response to treatment.
Topics: 22q11 Deletion Syndrome; Adult; Cohort Studies; Deep Brain Stimulation; Female; France; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenotype; Treatment Outcome | 2017 |